March 2020

Our first issue of 2020 focuses on companies and dealmaking activity in oncology as well as a review of the 2019 M&As.

About this edition

Our first issue of the year covers companies focusing on new therapies for the treatment of oncology. The feature editorials cover recent oncology dealmaking trends and a review of the M&As that took place in 2019.

Read the full issue here